000 | 01641 a2200445 4500 | ||
---|---|---|---|
005 | 20250512054827.0 | ||
264 | 0 | _c19870710 | |
008 | 198707s 0 0 eng d | ||
022 | _a0195-9417 | ||
024 | 7 |
_a10.1017/s0195941700065802 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBacon, A E | |
245 | 0 | 0 |
_aEmergence of nosocomial methicillin-resistant Staphylococcus aureus and therapy of colonized personnel during a hospital-wide outbreak. _h[electronic resource] |
260 |
_bInfection control : IC _cApr 1987 |
||
300 |
_a145-50 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S. | ||
650 | 0 | 4 |
_aCarrier State _xdrug therapy |
650 | 0 | 4 |
_aCross Infection _xepidemiology |
650 | 0 | 4 | _aDisease Outbreaks |
650 | 0 | 4 | _aDisease Reservoirs |
650 | 0 | 4 |
_aDrug Combinations _xtherapeutic use |
650 | 0 | 4 | _aHospitals, General |
650 | 0 | 4 | _aHospitals, Veterans |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMethicillin _xpharmacology |
650 | 0 | 4 | _aMichigan |
650 | 0 | 4 | _aPenicillin Resistance |
650 | 0 | 4 | _aRecurrence |
650 | 0 | 4 |
_aRifampin _xtherapeutic use |
650 | 0 | 4 |
_aStaphylococcal Infections _xdrug therapy |
650 | 0 | 4 |
_aStaphylococcus aureus _xdrug effects |
650 | 0 | 4 |
_aSulfamethoxazole _xtherapeutic use |
650 | 0 | 4 |
_aTrimethoprim _xtherapeutic use |
650 | 0 | 4 | _aTrimethoprim, Sulfamethoxazole Drug Combination |
700 | 1 | _aJorgensen, K A | |
700 | 1 | _aWilson, K H | |
700 | 1 | _aKauffman, C A | |
773 | 0 |
_tInfection control : IC _gvol. 8 _gno. 4 _gp. 145-50 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1017/s0195941700065802 _zAvailable from publisher's website |
999 |
_c3501244 _d3501244 |